From [HERE] Ever since the roll out of the experimental COVID-19 “vaccines” there has been abundant anecdotal evidence of “vaccine shedding,” where individuals who received one of the experimental mRNA injections were somehow also infecting those around them, even those who were unvaccinated.

Now there are some published studies that explain how the mechanism of this “shedding” might be happening, as well as evidence from Pfizer themselves according to their internal documents that they have been forced to release to the public.

One of those studies was published by Dr. Helene Banoun in the journal Infectious Disease Research.

Abstract

The massive COVID-19 vaccination campaign is the first time that mRNA vaccines havebeen used on a global scale. The mRNA vaccines correspond exactly to the definition of gene therapy of the American and European regulatory agencies. The  regulations require excretion studies of these drugs and their products (the translated proteins). These studies have not been  done for mRNA vaccines (nor for adenovirus vaccines). There are numerous reports of symptoms and pathologies identical to  the adverse effects of mRNA vaccines in unvaccinated persons in contact with freshly vaccinated persons. It is therefore  important to review the state of knowledge on the possible excretion of vaccine nano particles as well as mRNA and its product, the spike protein.

Vaccine mRNA-carrying lipid nano particles spread after injection throughout the  body according to available animal studies and vaccine mRNA (naked or in nano particles or innatural exosomes) is found in the bloodstream as well as vaccine spike in free form or encapsulated in exosomes (shown in human studies). Lipid nano particles (or their natural equivalent, exosomes or extracellular vesicles (EVs)) have been shown to be able to be excreted  through body fluids (sweat, sputum, breast milk) and to pass the transplacental barrier. These EVs are also able to penetrate by inhalation and through the skin (healthy or injured) as well as orally through breast milk (and why not during sexual intercourse through semen, as this has not been studied). It is urgent to enforce the legislation on gene therapy that applies to mRNA vaccines and to carry out studies on this subject while the generalization of mRNA vaccines is being considered.

Dr. Peter McCullough recently addressed this study.

From Dr. McCullough’s Substack Blog:

Health of Pure Bloods Threatened by Shedding of mRNA and Spike Protein

Why the Unvaccinated are Concerned about Close Contact with COVID-19 Vaccinated

One of the most common questions I am asked from the unvaccinated stems from concerns over “shedding.” Because the mRNA vaccines have been in development by the US Department of Defense DARPA since 2011, one would have expected that all of the necessary preclinical testing would have been completed before Operation Warp Speed was announced.

The 2015 FDA guidance on Gene Product Shedding Studies with gene therapies, which are defined as “all products that exert their effects by transcription and/or translation of transferred genetic material and/or by integration into the host genome and that are administered in the form of nucleic acids, viruses or genetically modified microorganisms”.

By this statement mRNA vaccines are indeed gene therapy products and should have been submitted to these excretion studies by DARPA funded researchers long ago.

Sadly, these careful development steps were skipped from the beginning in our military-style vaccine development program, and now the public is grappling with the issue of nucleic acid and Spike protein shedding as a potential concern among those who have worked so hard to remain healthy and free of COVID-19 vaccination.

In the most comprehensive paper on shedding thus far, former Inserm researcher Dr. Helene Banoun has published the basis for which there is great likelihood that mRNA either on lipid nanoparticles or within exosomes is circulatory in blood and is secreted in every body secretion that would naturally expect to contain particles of this size.

Fertig et al, have shown mRNA is circulatory in blood for at least two weeks with no reduction in concentration out to that time point. Likewise, Hanna et al, have found mRNA within breast milk.

Less data exist on Spike protein shedding but it is not a far stretch to understand this is well within the realm of reality. The pivotal questions are: 1) for how long is a recently vaccinated person at risk to shed on to others? 2) can shed mRNA be taken up by the recipient and begin to produce Spike protein just like vaccination? 3) can shed Spike protein cause disease as it does in the vaccinated (e.g. myocarditis, blood clots, etc.)?

It’s time for the lapses by DOD BARDA and NIH BARDA, to immediately be corrected by those agencies funding the necessary independent shedding studies to ensure the public safety of those who wisely deferred on COVID-19 vaccination.

This research should preferably be conducted while the current products are paused and taken off to market to protect others at risk. Until then, we simply cannot answer these questions for those who sacrificed so much to remain “pure-blood.” (Full article.)

Another study has been published on the Preprint Server Medrxiv.org titled: Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity. [MORE]